Methodological flaws, limitations, and inadequate practices in research are well known and pose threats to the internal validity of any research study. However, there are ways of safeguarding research conduct to reduce the chance of research producing distorted results. Numerous tools now exist to assess the incorporation of such safeguards into primary research studies (also known as quality and/or risk-of-bias assessment). These tools typically include a variety of items that are then checked against those implemented in the study. Despite a lot of research in this area, no comprehensive generic classification of safeguards across study designs exist, although attempts have been made to clarify aspects of this. We review the developments ...
International audienceThe objective of the study was to develop and validate an adequate tool to eva...
It is important to evaluate risk of bias of the primary studies included in systematic reviews and m...
Abstract. Even though randomised controlled trials are the design of choice for evaluating the effic...
Methodological flaws, limitations, and inadequate practices in research are well known and pose thre...
BACKGROUND: Evidence based medicine aims to integrate scientific evidence, clinical experience, and ...
Item does not contain fulltextOBJECTIVE: This paper presents a unified framework for assessment of t...
BACKGROUND: Evidence based medicine aims to integrate scientific evidence, clinical experience, and ...
The quality of a clinical study depends on internal and external factors. Studies have internal vali...
Background Several scales, checklists and domain-based tools for assessing risk of reporting biases ...
Methods to assess the risk of bias in a way that is reliable, reproducible. and transparent to reade...
The increasing application of research synthesis into policy and practice has generated an increasin...
Abstract Background Assessing the risk of bias in individual studies in a systematic review can be d...
We expect every research study to have some inherent random error because samples cannot exactly ref...
Abstract Risk of bias in translational medicine may take one of three forms: A. a systematic error o...
Even though randomised controlled trials are the design of choice for evaluating the efficacy of hea...
International audienceThe objective of the study was to develop and validate an adequate tool to eva...
It is important to evaluate risk of bias of the primary studies included in systematic reviews and m...
Abstract. Even though randomised controlled trials are the design of choice for evaluating the effic...
Methodological flaws, limitations, and inadequate practices in research are well known and pose thre...
BACKGROUND: Evidence based medicine aims to integrate scientific evidence, clinical experience, and ...
Item does not contain fulltextOBJECTIVE: This paper presents a unified framework for assessment of t...
BACKGROUND: Evidence based medicine aims to integrate scientific evidence, clinical experience, and ...
The quality of a clinical study depends on internal and external factors. Studies have internal vali...
Background Several scales, checklists and domain-based tools for assessing risk of reporting biases ...
Methods to assess the risk of bias in a way that is reliable, reproducible. and transparent to reade...
The increasing application of research synthesis into policy and practice has generated an increasin...
Abstract Background Assessing the risk of bias in individual studies in a systematic review can be d...
We expect every research study to have some inherent random error because samples cannot exactly ref...
Abstract Risk of bias in translational medicine may take one of three forms: A. a systematic error o...
Even though randomised controlled trials are the design of choice for evaluating the efficacy of hea...
International audienceThe objective of the study was to develop and validate an adequate tool to eva...
It is important to evaluate risk of bias of the primary studies included in systematic reviews and m...
Abstract. Even though randomised controlled trials are the design of choice for evaluating the effic...